Drug Target Development and Validation for Antimicrobial-Resistant Pathogens (R21/R33)

Drug Target Development and Validation for Antimicrobial-Resistant Pathogens (R21/R33)
Activity Code	R21/R33 Phased Innovation Award
Announcement Type	New
Related Notices	None
Funding Opportunity Announcement (FOA) Number	RFA-AI-13-019
Companion Funding Opportunity	None
Number of Applications	See Section III. 3. Additional Information on Eligibility.
Catalog of Federal Domestic Assistance (CFDA) Number(s)	93.855; 93.856
Funding Opportunity Purpose	To support basic to translational research focused on characterization and validation of novel antimicrobial targets for development of new therapeutic interventions against select antimicrobial-resistant bacterial pathogens.

Key Dates

Posted Date	March 26, 2013
Open Date (Earliest Submission Date)	June 18, 2013
Letter of Intent Due Date(s)	June 18, 2013
Application Due Date(s)	July 18, 2013, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.